Fig. 2From: Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementiaHigh diagnostic performance of Aβ1–42 and SS-16 for MCI converting to AD dementia. a showed ROC analysis of Aβ1–42 and SS-16 respectively and in combination for MCI-c and MCI-nc in a 2-year follow-up. b showed ROC analysis of Aβ1–42 and SS-16 respectively and in combination for MCI-c and MCI-nc in a 3-year follow-upBack to article page